Here are the DEF 14A proxy statements from OrthoPediatrics Corp. (KIDS) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow KIDS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KIDS filings page.
OrthoPediatrics Corp. has called its 2026 annual meeting for June 4 to elect four directors, hold advisory votes on executive pay and auditor appointment, and approve an amendment to its 2024 Incentive Award Plan. As of April 6, 2026, 25,686,214 common shares were outstanding, each with one vote. The proxy details board structure, committee independence, social impact focus, and a pay program where 2025 bonuses for named executives paid out at 78.2% of target and long-term incentives were delivered in time-vested restricted stock.